Patent · US Active

Fibronectin based scaffold domain proteins that bind IL-23

US9260496B2 · kind B2 · utility

0Cited by

10References

4Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Ruchira Dasgupta · Waltham, US
Steven Sheriff · Princeton, US
Anzhi Wei · Newtown, US
Vidhyashankar Ramamurthy · Kanchinakote, IN
Alex Bush · Watertown, US
Katie A. Russo · Watertown, US
Linda Engle · Framingham, US

Key dates

Filing date	Dec 20, 2011
Grant date	Feb 16, 2016
Priority date	—
Expiry date	Dec 20, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/50
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to fibronectin based scaffold domain protein that bind interleukin 23 (IL-23). The invention also relates to the use of the innovative proteins in therapeutic applications to treat autoimmune diseases. The invention further relates to cells comprising such proteins, polynucleotide encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the innovative proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.